|
Jul 17
|
OPKO Health and HealthCare Royalty Enter into $250 Million Note Purchase Agreement Secured by NGENLA’s Profit Share Payments
|
|
Jun 6
|
Why Is OPKO Health (OPK) Up 12.8% Since Last Earnings Report?
|
|
May 9
|
OPKO Health's (OPK) Q1 Earnings Miss Estimates, Sales Down Y/Y
|
|
May 8
|
OPKO Health, Inc. (NASDAQ:OPK) Q1 2024 Earnings Call Transcript
|
|
May 8
|
Q1 2024 OPKO Health Inc Earnings Call
|
|
May 8
|
OPKO Health Inc (OPK) Q1 2024 Earnings Call Transcript Highlights: Strategic Moves Amid ...
|
|
May 8
|
Opko Health (OPK) Q1 2024 Earnings Call Transcript
|
|
May 8
|
OPKO Health (OPK) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
|
|
May 7
|
OPKO Health Inc (OPK) Q1 2024 Earnings: Misses Revenue and Earnings Estimates
|
|
May 7
|
OPKO Health (OPK) Reports Q1 Loss, Misses Revenue Estimates
|
|
May 7
|
OPKO Health Reports First Quarter 2024 Business Highlights and Financial Results
|
|
May 3
|
OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2024
|
|
Apr 1
|
OPKO Health (OPK) to Restructure After Asset Buyout by Labcorp
|
|
Apr 1
|
Labcorp (LH) to Boost Clinical Diagnostics With New Deal
|
|
Mar 29
|
Labcorp inks $237.5M buyout of Opko’s reproductive, women’s health testing assets
|
|
Mar 28
|
Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business
|
|
Mar 25
|
OPKO Health (OPK) And Entera Bio Announce Data for GLP-2
|
|
Mar 20
|
Entera Bio Announces Robust Pharmacokinetic Data for First-in-Class Oral GLP-2 Peptide Tablet Treatment for Patients with Short Bowel Syndrome
|
|
Mar 5
|
AIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX Trispecific Antibody for the Treatment and Prevention of HIV
|
|
Jan 11
|
Shockwave Medical (SWAV) Surges 7.8%: Is This an Indication of Further Gains?
|